These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8876027)

  • 1. Persisting changes in brain glucose uptake following neurotoxic doses of phencyclidine which mirror the acute effects of the drug.
    Ellison GD; Keys AS
    Psychopharmacology (Berl); 1996 Aug; 126(3):271-4. PubMed ID: 8876027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.
    Ellison G
    Brain Res Brain Res Rev; 1995 Feb; 20(2):250-67. PubMed ID: 7795658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term changes in brain following continuous phencyclidine administration: an autoradiographic study using flunitrazepam, ketanserin, mazindol, quinuclidinyl benzilate, piperidyl-3,4-3H(N)-TCP, and AMPA receptor ligands.
    Ellison G; Keys A; Noguchi K
    Pharmacol Toxicol; 1999 Jan; 84(1):9-17. PubMed ID: 9974184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phencyclidine produces changes in NMDA and kainate receptor binding in rat hippocampus over a 48-hour time course.
    Gao XM; Tamminga CA
    Synapse; 1996 Aug; 23(4):274-9. PubMed ID: 8855512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of zif268 mRNA in rat retrosplenial cortex following administration of phencyclidine.
    Shirayama Y; Hashimoto K; Matsuki H; Tsunashima K; Iyo M; Higuchi T; Minabe Y
    Brain Res; 1999 Aug; 839(1):180-5. PubMed ID: 10482811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCP-induced alterations in cerebral glucose utilization in rat brain: blockade by metaphit, a PCP-receptor-acylating agent.
    Tamminga CA; Tanimoto K; Kuo S; Chase TN; Contreras PC; Rice KC; Jackson AE; O'Donohue TL
    Synapse; 1987; 1(5):497-504. PubMed ID: 2850626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.
    Johnson KM; Phillips M; Wang C; Kevetter GA
    J Neurosci Res; 1998 Jun; 52(6):709-22. PubMed ID: 9669320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long term changes in NMDA receptor binding in mouse brain following chronic phencyclidine treatment.
    Newell KA; Zavitsanou K; Huang XF
    J Neural Transm (Vienna); 2007; 114(8):995-1001. PubMed ID: 17401537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed regional metabolic actions of phencyclidine.
    Gao XM; Shirakawa O; Du F; Tamminga CA
    Eur J Pharmacol; 1993 Sep; 241(1):7-15. PubMed ID: 8223927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phencyclidine (PCP)-induced disruption in cognitive performance is gender-specific and associated with a reduction in brain-derived neurotrophic factor (BDNF) in specific regions of the female rat brain.
    Snigdha S; Neill JC; McLean SL; Shemar GK; Cruise L; Shahid M; Henry B
    J Mol Neurosci; 2011 Mar; 43(3):337-45. PubMed ID: 20852970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive and non-competitive NMDA antagonists induce similar limbic degeneration.
    Ellison G
    Neuroreport; 1994 Dec; 5(18):2688-92. PubMed ID: 7696633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phencyclidine on immediate early gene expression in the brain.
    Näkki R; Sharp FR; Sagar SM; Honkaniemi J
    J Neurosci Res; 1996 Jul; 45(1):13-27. PubMed ID: 8811509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice.
    Beraki S; Diaz-Heijtz R; Tai F; Ogren SO
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):243-55. PubMed ID: 18684341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic phencyclidine increases NMDA receptor NR1 subunit mRNA in rat forebrain.
    Wang C; Showalter VM; Hillman GR; Johnson KM
    J Neurosci Res; 1999 Mar; 55(6):762-9. PubMed ID: 10220116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increase in NMDA-sensitive [3H]glutamate and [3H]kainate binding in hippocampus 24 hours after PCP.
    Gao XM; Tamminga CA
    Neurosci Lett; 1994 Jun; 174(2):149-53. PubMed ID: 7970171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
    Umino A; Takahashi K; Nishikawa T
    Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists.
    Sharkey J; Ritchie IM; Butcher SP; Kelly JS
    Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.
    Gozzi A; Schwarz A; Crestan V; Bifone A
    Magn Reson Imaging; 2008 Sep; 26(7):999-1006. PubMed ID: 18486387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in local cerebral glucose utilization induced by phencyclidine.
    Weissman AD; Dam M; London ED
    Brain Res; 1987 Dec; 435(1-2):29-40. PubMed ID: 3427457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.